Merus Labs International Stock Price (NASDAQ:MSLI)

Add to My Stocks
$0.87 $0.01 (1.16%) MSLI stock closing price Feb 21, 2017 (Closing)
Prev Close* : $0.86
Market Cap:
Day Low: $0.86
52 Week Low: $0.70
Open: $0.86
Volume: 6675
Day High: $0.88
52 Week High: $1.76

Latest Stock Market News

Latest Articles

Merus Labs International News - From Partners

Merus Labs Announces Record Q1 2015 Results   by Marketwired on Feb 11, 2015
Merus Labs Announces Management & Board Changes   by Marketwired on Sep 23, 2014

MSLI Stockcharts

View MSLI PE ratio, PS ratio stocks charts and compare with peers.
MSLI Chart
Note: Compare Merus Labs International stock price history with the index and industry peers.

Merus Labs International Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Merus Labs International Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

MSLI Industry Peers

Company Price Change (%)
Recro Pharma (REPH)7.720.07 (0.9%)
Cumberland Pharma (CPIX)5.590.12 (2.1%)
Novartis (NVS)77.040.16 (0.21%)
Aquinox Pharma (AQXP)17.760.53 (2.9%)
Teva Pharmaceutical (TEVA)36.651.45 (4.12%)
Eisai (ESALY)54.50.1 (0.18%)
Merck (MRK)65.480.09 (0.14%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sucampo Pharma (SCMP)12.60.8 (6.78%)
Portola Pharma (PTLA)32.660.98 (3.09%)
Genocea Biosciences (GNCA)4.740.14 (3.04%)
Aratana Therapeutics (PETX)6.530.19 (3%)
Zogenix (ZGNX)10.50.3 (2.94%)
Nektar Therapeutics (NKTR)13.410.31 (2.37%)
Flexion Therapeutics (FLXN)19.660.43 (2.24%)
Top gainers from Medical-Drugs industry
* As of Feb 21, 2017
CompanyPriceChange (%)
BioCryst Pharma (BCRX)6.10.46 (7.01%)
CTI BioPharma (CTIC)4.460.27 (5.71%)
Ignyta (RXDX)9.10.5 (5.21%)
PTC Therapeutics (PTCT)13.50.66 (4.66%)
La Jolla Pharma (LJPC)18.090.88 (4.64%)
Cempra (CEMP)3.20.15 (4.48%)
Tetraphase Pharmaceuticals (TTPH)5.190.24 (4.42%)
Top losers from Medical-Drugs industry
* As of Feb 21, 2017

Merus Labs International Financial Statements

income statement20162015201420132012
Net Sales Or Revenues68.78M39.97M24.17M27.97M10.34M
Net Income-7.14M-0.19M-7.45M-3.05M-20.56M
Total Operating Expense45.9M28.75M20.84M18.54M9.58M
view Merus Labs International Inc (USA) income statement
balance sheet20162015201420132012
Total Assets283.49M215.56M183.22M85.76M91.7M
Total Liabilities134.13M67.92M77.24M42.49M56.69M
Shareholders Equity149.35M147.63M105.98M43.27M35M
view Merus Labs International Inc (USA) balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-8.81M-8.52M-1.32M0.94M-2.06M
Net Cash From (Used By) Operating Activities16.67M16.61M11.79M12.3M1.75M
Increase (Decrease) In Prop Plant And Equipment-0.17M--0.11M-0.01M-
view Merus Labs International Inc (USA) cashflow statement

Merus Labs International Inc (USA) Stock News - Partner Headlines

Merus Labs International Stock Message Board

Merus Labs International stock price ended the last trading day at 0.86. The total market value as denoted by 100.92M for Merus Labs International, is the market value of the company's outstanding shares. Merus Labs International valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy MSLI stock than sell it, then Merus Labs International stock price goes up. Conversely, if more investors wanted to sell MSLI stock than buy it, there would be greater supply than demand, and the stock price would fall. 9750 shares were traded with a closing stock price of 0.86 as of 17 Feb, 2017, as can be seen from Merus Labs International stock quote. One can view Merus Labs International stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Merus Labs International does not pay dividends. Merus Labs International stock price history, gives the entire historical data for MSLI stock.